Mitochondria Defects in Brains of Parkinson’s Patients Might Play Protective Role
Defects in mitochondria, the cell’s microscopic powerhouses, might actually protect Parkinson’s disease patients, a Norwegian study suggests. The findings show that,…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Defects in mitochondria, the cell’s microscopic powerhouses, might actually protect Parkinson’s disease patients, a Norwegian study suggests. The findings show that,…
Patients with rapid eye movement sleep behavior disorder, or RBD, have a form of inflammation in the brain that puts…
Using low-frequency electrical pulses to stimulate a deep brain region can improve the cognitive function of people with Parkinson’s and other…
Women with Parkinson’s disease are less likely to have caregiver support, and are more frequent users of formal, paid caregiver…
Researchers at Scripps Research Institute in La Jolla, California, have uncovered a molecular mechanism that links Parkinson’s disease and environmental…
Horizon Discovery, in a collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), has developed two…
Anavex 2-73, an investigational therapy being evaluated in clinical trials for Alzheimer’s disease, was found to restore the function of damaged nerve…
Researchers at Roche’s innovation center in Basel, Switzerland, have identified four small molecule therapy candidates that target the neurotensin receptor,…
Acadia Pharmaceuticals is starting a new Phase 3 clinical trial testing the efficacy of pimavanserin to treat the hallucinations and delusions associated…
Researchers at the Washington University School of Medicine (WUSM) in St. Louis developed a new computational method that can help…
Get regular updates to your inbox.